Associated Papers
Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases.
Fischer GM et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2025
SMARCA4-deficient central nervous system metastases: A case series and systematic review.
Morris M et al.
Journal of Neuropathology and Experimental Neurology, 2024
Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling.
Higuchi R et al.
Jto Clinical and Research Reports, 2021
34877557 (PubMed )
Supplement: mmc2.pdf
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts.
Kemper K et al.
Cell Reports, 2016
27320919 (PubMed )
Supplement: mmc2.xlsx › Mutation_matrix
Select a paper to view details